Dikkat Eksikliği Hiperaktivite Bozukluğu’nda Yeni Tedavi Yaklaşımları

Ayano, G., Demelash, S., Gizachew, Y., Tsegay, L., & Alati, R. (2023). The global prevalence of attention deficit hyperactivity disorder in children and adolescents: An umbrella review of meta-analyses. Journal of Affective Disorders, 339, 860–866.

Sibley, M. H., Bruton, A. M., Zhao, X., Johnstone, J. M., Mitchell, J., Hatsu, I., Arnold, L. E., Basu, H. H., Levy, L., Vyas, P., Macphee, F., Gonzalez, E. S., Kelley, M., Jusko, M. L., Bolden, C. R., Zulauf-McCurdy, C., Manzano, M., & Torres, G. (2023). Non-pharmacological interventions for attention-deficit hyperactivity disorder in children and adolescents. The Lancet Child and Adolescent Health, 7(6), 415–428.

Pollak, Y., Dekkers, T. J., Shoham, R., & Huizenga, H. M. (2019). Risk-Taking Behavior in Attention Deficit/Hyperactivity Disorder (ADHD): a Review of Potential Underlying Mechanisms and of Interventions. Current Psychiatry Reports, 21(5), 1–11.

Baweja, R., Faraone, S. V., Childress, A. C., Weiss, M. D., Loo, S. K., Wilens, T. E., & Waxmonsky, J. G. (2024). From Consensus Statement to Pills to Pixels: New Innovations in Attention-Deficit/Hyperactivity Disorder Care. Journal of Child and Adolescent Psychopharmacology, 34(4), 167–182.

Koirala, S., Grimsrud, G., Mooney, M. A., Larsen, B., Feczko, E., Elison, J. T., Nelson, S. M., Nigg, J. T., Tervo-Clemmens, B., & Fair, D. A. (2024). Neurobiology of attention-deficit hyperactivity disorder: historical challenges and emerging frontiers. Nature Reviews Neuroscience 2024 25:12, 25(12), 759–775.

Boudreau, A., & Mah, J. W. T. (2020). Predicting Use of Medications for Children with ADHD: The Contribution of Parent Social Cognitions. Journal of the Canadian Academy of Child and Adolescent Psychiatry, 29(1), 26.

Childress, A. C., Cutler, A. J., Marraffino, A., McDonnell, M. A., Turnbow, J. M., Brams, M., DeSousa, N. J., Incledon, B., Sallee, F. R., & Wigal, S. B. (2020). A Randomized, Double-Blind, Placebo-Controlled Study of HLD200, a Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder: An Evaluation of Safety and Efficacy Throughout the Day and Across Settings. Journal of Child and Adolescent Psychopharmacology, 30(1), 2.

ADHANSIA XR (methylphenidate hydrochloride) extended-release capsules, for oral use, CII. (n.d.). Retrieved December 11, 2024, from https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212038Orig1s000lbl.pdf

Katzman, M. A., Mattingly, G., Klassen, L. J., Cataldo, M. J., & Donnelly, G. A. E. (2020). Randomized Controlled Crossover Trials of the Pharmacokinetics of PRC-063, a Novel Multilayer Extended-Release Formulation of Methylphenidate, in Healthy Adults. Journal of Clinical Psychopharmacology, 40(6), 579–587.

Childress, A. C., Brams, M. N., Cutler, A. J., Donnelly, G. A. E., & Bhaskar, S. (2020). Efficacy and Safety of Multilayer, Extended-Release Methylphenidate (PRC-063) in Children 6-12 Years of Age with Attention-Deficit/Hyperactivity Disorder: A Laboratory Classroom Study. Journal of Child and Adolescent Psychopharmacology, 30(10), 580–589.

Cataldo, M., Donnelly, G., Cutler, A. J., Childress, A., Mikl, J., Bhaskar, S., & Waxmonsky, J. (2022). Analysis of Daily Sleep Diary Measures From Multilayer Extended-Release Methylphenidate (PRC-063) Studies in Children and Adults With ADHD. Journal of Attention Disorders, 26(14), 1870–1881.

Kollins, S. H., Braeckman, R., Guenther, S., Barrett, A. C., Mickle, T. C., Oh, C., Marraffino, A., Cutler, A. J., & Brams, M. N. (2021). A Randomized, Controlled Laboratory Classroom Study of Serdexmethylphenidate and d-Methylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology, 31(9), 597–609.

Braeckman, R., Guenther, S., Mickle, T. C., Barrett, A. C., Smith, A., & Oh, C. (2022). Dose Proportionality and Steady-State Pharmacokinetics of Serdexmethylphenidate/Dexmethylphenidate, a Novel Prodrug Combination to Treat Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology, 32(5), 288–295.

Barnhardt, E. A., Narayanan, A. R., & Coury, D. L. (2023). Evaluating serdexmethylphenidate and dexmethylphenidate capsules as a once-daily treatment option for ADHD. Expert Opinion on Pharmacotherapy, 24(11), 1215–1219.

Childress, A. C., Marraffino, A., Cutler, A. J., Oh, C., & Brams, M. N. (2023). Safety and Tolerability of Serdexmethylphenidate/Dexmethylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder: A 12-Month, Open-Label Safety Study. Journal of Child and Adolescent Psychopharmacology, 33(2), 51–58.

Faraone, S. V., Childress, A. C., Gomeni, R., Rafla, E., Kando, J. C., Dansie, L., Naik, P., & Pardo, A. (2023). Efficacy of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder: Effect Size Across the Day. Journal of Child and Adolescent Psychopharmacology, 33(1), 14–19.

Pardo, A., Kando, J. C., King, T. R., Rafla, E., & Herman, B. K. (2020). Single-dose pharmacokinetics of amphetamine extended-release tablets compared with amphetamine extended-release oral suspension. CNS Spectrums, 25(6), 774–781.

Allain, J. E., & Ganem, J. A. (2024). Dextroamphetamine Transdermal Patch: A Treatment Option for Attention-Deficit/Hyperactivity Disorder. Journal for Nurse Practitioners, 20(5). https://doi.org/10.1016/j.nurpra.2024.104993

Cutler, A. J., Suzuki, K., Starling, B., Balakrishnan, K., Komaroff, M., Castelli, M., Meeves, S., & Childress, A. C. (2022). Efficacy and Safety of Dextroamphetamine Transdermal System for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Results from a Pivotal Phase 2 Study. Journal of Child and Adolescent Psychopharmacology, 32(2), 89–97.

Childress, A., & Vaughn, N. (2024). A critical review of the dextroamphetamine transdermal system for the treatment of ADHD in adults and pediatric patients. Expert Review of Neurotherapeutics, 24(5), 457–464.

Cutler, A. J., Suzuki, K., Starling, B., Balakrishnan, K., Komaroff, M., Meeves, S., Castelli, M., & Childress, A. (2023). d-Amphetamine Transdermal System in Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: Secondary Endpoint Results and Post Hoc Effect Size Analyses from a Pivotal Trial. Journal of Child and Adolescent Psychopharmacology, 33(5), 176–182.

Childress, A., & Burton, S. (2022). Evaluating the pharmacokinetics of extended release viloxazine in the treatment of children with attention-deficit/hyperactivity disorder. Expert Opinion on Drug Metabolism & Toxicology, 18(6), 357–366.

Yu, C., Garcia-Olivares, J., Candler, S., Schwabe, S., & Maletic, V. (2020). New Insights into the Mechanism of Action of Viloxazine: Serotonin and Norepinephrine Modulating Properties. Journal of Experimental Pharmacology, 12, 285–300.

Nasser, A., Gomeni, R., Hull, J., Maldonado-Cruz, Z., Earnest, J., & Rubin, J. (2023). Evaluating the Impact of Caffeine on the Incidence of Adverse Events During Treatment with Viloxazine Extended-Release (Qelbree®) in Adults with ADHD. CNS Spectrums, 28(2), 234–235. https://doi.org/10.1017/S1092852923001621

Yu, C. L., Kao, Y. C., Thompson, T., Stubbs, B., Tseng, P. T., Hsu, C. W., Yang, F. C., Tu, Y. K., Hsu, T. W., & Liang, C. S. (2024). Response Trajectories and Temporal Trends of Viloxazine Treatment for Young People With ADHD: A Meta-Analysis. JAMA Network Open, 7(11), e2445885. https://doi.org/10.1001/JAMANETWORKOPEN.2024.45885

Faison, S. L., Fry, N., Adewole, T., Odebo, O., Schwabe, S., Wang, Z., Maletic, V., & Nasser, A. (2021). Pharmacokinetics of Coadministered Viloxazine Extended-Release (SPN-812) and Methylphenidate in Healthy Adults. Clinical Drug Investigation, 41(2), 149–159.

Faison, S. L., Fry, N., Adewole, T., Odebo, O., Wang, Z., Maletic, V., & Nasser, A. (2021). Pharmacokinetics of Coadministered Viloxazine Extended-Release (SPN-812) and Lisdexamfetamine in Healthy Adults. Journal of Clinical Psychopharmacology, 41(2), 155–162.

Neuchat, E. E., Bocklud, B. E., Kingsley, K., Barham, W. T., Luther, P. M., Ahmadzadeh, S., Shekoohi, S., Cornett, E. M., & Kaye, A. D. (2023). The Role of Alpha-2 Agonists for Attention Deficit Hyperactivity Disorder in Children: A Review. Neurology International, 15(2), 697.

Naguy, A., Alayadhi, N., Al-Tajali, A., & Ozidu, V. (2024). 2024 FDA-approved psychotropic medications: A conspectus. Asian Journal of Psychiatry, 102.

Jain, R., Segal, S., Kollins, S. H., & Khayrallah, M. (2011). Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 50(2), 171–179.

Cortese, S. (2023). Evidence-based prescribing of medications for ADHD: where are we in 2023? Expert Opinion on Pharmacotherapy, 24(4), 425–434.

Naguy, A., Pridmore, S., Alwetayan, S., Elsori, D., & Alamiri, B. (2023). ADHD-A Clinician’s Bird’s Eye View of Current Status and New Vistas! Psychopharmacology Bulletin, 53(1), 46.

Schein, J., Cloutier, M., Gauthier-Loiselle, M., Catillon, M., Xu, C., Chan, D., & Childress, A. (2024). Assessment of centanafadine in adults with attention-deficit/hyperactivity disorder: A matching-adjusted indirect comparison vs lisdexamfetamine dimesylate, atomoxetine hydrochloride, and viloxazine extended-release. Journal of Managed Care & Specialty Pharmacy, 30(6), 528.

Surman, C. B. H., Walsh, D. M., Horick, N., DiSalvo, M., Vater, C. H., & Kaufman, D. (2023). Solriamfetol for Attention-Deficit/Hyperactivity Disorder in Adults: A Double-Blind Placebo-Controlled Pilot Study. The Journal of Clinical Psychiatry, 84(6).

Maiti, R., Mishra, A., Jena, M., Maji, S., Padhan, M., & Mishra, B. R. (2024). Efficacy and safety of dasotraline in attention-deficit hyperactivity disorder: A systematic review and meta-analysis. Indian Journal of Psychiatry, 66(4), 326–335.

IsHak, W. W., Meyer, A., Freire, L., Totlani, J., Murphy, N., Renteria, S., Salem, M., Chang, T., Abdelsalam, R., Khan, R., Chandy, T., Parrish, T., Hirsch, D., Patel, B., Steiner, A. J., Kim, S., Hedrick, R., Pechnick, R. N., & Danovitch, I. (2024). Overview of Psychiatric Medications in the Pipeline in Phase III Trials as of June 1, 2024: A Systematic Review. Innovations in Clinical Neuroscience, 21(7–9), 27.

Rubia, K., Westwood, S., Aggensteiner, P. M., & Brandeis, D. (2021). Neurotherapeutics for Attention Deficit/Hyperactivity Disorder (ADHD): A Review. Cells, 10(8).

Rubia, K. (2022). Neurotherapeutics for ADHD: Do they work? PsyCh Journal, 11(3), 419–427.

Westwood, S. J., Radua, J., & Rubia, K. (2021). Noninvasive brain stimulation in children and adults with attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. Journal of Psychiatry & Neuroscience : JPN, 46(1), E14–E33.

Memon, A. M. (2021). Transcranial Magnetic Stimulation in Treatment of Adolescent Attention Deficit/Hyperactivity Disorder: A Narrative Review of Literature. Innovations in Clinical Neuroscience, 18(1–3), 43.

Chen, Y. H., Liang, S. C., Sun, C. K., Cheng, Y. S., Tzang, R. ‐F, Chiu, H. ‐J, Wang, M. Y., Cheng, Y. C., & Hung, K. C. (2023). A meta-analysis on the therapeutic efficacy of repetitive transcranial magnetic stimulation for cognitive functions in attention-deficit/hyperactivity disorders. BMC Psychiatry, 23(1).

Narmashiri, A., & Akbari, F. (2023). The Effects of Transcranial Direct Current Stimulation (tDCS) on the Cognitive Functions: A Systematic Review and Meta-analysis. Neuropsychology Review.

Brauer, H., Breitling-Ziegler, C., Moliadze, V., Galling, B., & Prehn-Kristensen, A. (2021). Transcranial direct current stimulation in attention-deficit/hyperactivity disorder: A meta-analysis of clinical efficacy outcomes. Progress in Brain Research, 264, 91–116.

Salehinejad, M. A., Nejati, V., Mosayebi-Samani, M., Mohammadi, A., Wischnewski, M., Kuo, M. F., Avenanti, A., Vicario, C. M., & Nitsche, M. A. (2020). Transcranial Direct Current Stimulation in ADHD: A Systematic Review of Efficacy, Safety, and Protocol-induced Electrical Field Modeling Results. Neuroscience Bulletin, 36(10), 1191–1212.

Westwood, S. J., Conti, A. A., Tang, W., Xue, S., Cortese, S., & Rubia, K. (2023). Clinical and cognitive effects of external trigeminal nerve stimulation (eTNS) in neurological and psychiatric disorders: a systematic review and meta-analysis. Molecular Psychiatry, 28(10), 4025–4043.

Huus, C.-M. L., Edemann-Callesen, H., Darling-Rasmussen, P., Martinsen, Ø. G., Bikic, A., & Storebø, O. J. (2023). The use of external Trigeminal Nerve Stimulation as an initial treatment for ADHD symptoms in children: A qualitative study of case series reports. Psychiatry Research Case Reports, 2(2), 100154.

McGough, J. J., Sturm, A., Cowen, J., Tung, K., Salgari, G. C., Leuchter, A. F., Cook, I. A., Sugar, C. A., & Loo, S. K. (2019). Double-Blind, Sham-Controlled, Pilot Study of Trigeminal Nerve Stimulation for Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 58(4), 403-411.e3.

Moret, B., Donato, R., Nucci, M., Cona, G., & Campana, G. (2019). Transcranial random noise stimulation (tRNS): a wide range of frequencies is needed for increasing cortical excitability. Scientific Reports, 9(1).

Nejati, V., Dehghan, M., Shahidi, S., Estaji, R., & Nitsche, M. A. (2024). Transcranial random noise stimulation (tRNS) improves hot and cold executive functions in children with attention deficit-hyperactivity disorder (ADHD). Scientific Reports, 14(1).

Ornella, D. K., Noam, M., Shachar, H., Itai, B., Roi, C. K., & Mor, N. (2023). Transcranial random noise stimulation combined with cognitive training for treating ADHD: a randomized, sham-controlled clinical trial. Translational Psychiatry, 13(1).

Zhi, J., Zhang, S., Huang, M., Qin, H., Xu, H., Chang, Q., & Wang, Y. (2024). Transcutaneous auricular vagus nerve stimulation as a potential therapy for attention deficit hyperactivity disorder: modulation of the noradrenergic pathway in the prefrontal lobe. Frontiers in Neuroscience, 18, 1494272.

Cheung, T., Yee, B. K., Chau, B., Lam, J. Y. T., Fong, K. H., Lo, H., Li, T. M. H., Li, A. M., Sun, L., Beisteiner, R., & Cheng, C. P. W. (2024). Efficacy and safety of transcranial pulse stimulation in young adolescents with attention-deficit/hyperactivity disorder: a pilot, randomized, double-blind, sham-controlled trial. Frontiers in Neurology, 15.

Faraone, S. V., Bellgrove, M. A., Brikell, I., Cortese, S., Hartman, C. A., Hollis, C., Newcorn, J. H., Philipsen, A., Polanczyk, G. V., Rubia, K., Sibley, M. H., & Buitelaar, J. K. (2024). Attention-deficit/hyperactivity disorder. Nature Reviews Disease Primers 2024 10:1, 10(1), 1–21.

Gudka, R., Becker, K., Newlove-Delgado, T., & Price, A. (2024). Provision of digital health interventions for young people with ADHD in primary care: findings from a survey and scoping review. BMC Digital Health 2024 2:1, 2(1), 1–12.

Tamm, L., Loren, R. E. A., Peugh, J., & Ciesielski, H. A. (2021). The Association of Executive Functioning With Academic, Behavior, and Social Performance Ratings in Children With ADHD. Journal of Learning Disabilities, 54(2), 124–138.

Diamond, A. (2013). Executive Functions. Annual Review of Psychology, 64, 135.

Keshavan, M. S., Vinogradov, S., Rumsey, J., Sherrill, J., & Wagner, A. (2014). Cognitive training in mental disorders: update and future directions. The American Journal of Psychiatry, 171(5), 510–522.

Shams, T. A., Foussias, G., Zawadzki, J. A., Marshe, V. S., Siddiqui, I., Müller, D. J., & Wong, A. H. C. (2015). The Effects of Video Games on Cognition and Brain Structure: Potential Implications for Neuropsychiatric Disorders. Current Psychiatry Reports, 17(9).

Understanding DTx - Digital Therapeutics Alliance. (n.d.). Retrieved December 11, 2024, from https://dtxalliance.org/understanding-dtx/

Westwood, S. J., Parlatini, V., Rubia, K., Cortese, S., Sonuga-Barke, E. J. S., Banaschewski, T., Baeyens, D., Bölte, S., Brandeis, D., Buitelaar, J., Carucci, S., Coghill, D., Daley, D., Döpfner, M., Ferrin, M., Galera, C., Hollis, C., Holtmann, M., Purper-Ouakil, D., … Zuddas, A. (2023). Computerized cognitive training in attention-deficit/hyperactivity disorder (ADHD): a meta-analysis of randomized controlled trials with blinded and objective outcomes. Molecular Psychiatry 2023 28:4, 28(4), 1402–1414.

He, F., Qi, Y., Zhou, Y., Cao, A., Yue, X., Fang, S., & Zheng, Y. (2023). Meta-analysis of the efficacy of digital therapies in children with attention-deficit hyperactivity disorder. Frontiers in Psychiatry, 14.

Oh, S. A., Choi, J., Han, D. H., & Kim, E. Y. (2024). Effects of game-based digital therapeutics on attention deficit hyperactivity disorder in children and adolescents as assessed by parents or teachers: a systematic review and meta-analysis. European Child & Adolescent Psychiatry, 33(2), 481–493.

Liu, X., Yang, Y., Ye, Z., Wang, F., Zeng, K., Sun, Y., Huang, Y., & Dai, L. (2024). The effect of digital interventions on attention deficit hyperactivity disorder (ADHD): A meta-analysis of randomized controlled trials. Journal of Affective Disorders, 365, 563–577.

Zhan, J., Liu, C., Wang, Z., Cai, Z., & He, J. (2024). Effects of game-based digital interventions for mental disorders: A meta-analysis. Journal of Affective Disorders, 362, 731–741.

Gobet, F., & Sala, G. (2023). Cognitive Training: A Field in Search of a Phenomenon. Perspectives on Psychological Science : A Journal of the Association for Psychological Science, 18(1), 125–141.

Sala, G., Deniz Aksayli, N., Semir Tatlidil, K., Tatsumi, T., Gondo, Y., & Gobet, F. (2019). Near and far transfer in cognitive training: A second-order meta-analysis. Collabra: Psychology, 5(1).

Kassai, R., Futo, J., Demetrovics, Z., & Takacs, Z. K. (2019). A meta-analysis of the experimental evidence on the near- and far-transfer effects among children’s executive function skills. Psychological Bulletin, 145(2), 165–188.

Instructions For Use | EndeavorRx®. (n.d.). Retrieved December 9, 2024, from https://www.endeavorrx.com/instructions-for-use/

Kollins, S. H., DeLoss, D. J., Cañadas, E., Lutz, J., Findling, R. L., Keefe, R. S. E., Epstein, J. N., Cutler, A. J., & Faraone, S. V. (2020). A novel digital intervention for actively reducing severity of paediatric ADHD (STARS-ADHD): a randomised controlled trial. The Lancet Digital Health, 2(4), e168–e178.

Kollins, S. H., Childress, A., Heusser, A. C., & Lutz, J. (2021). Effectiveness of a digital therapeutic as adjunct to treatment with medication in pediatric ADHD. NPJ Digital Medicine, 4(1). https://doi.org/10.1038/S41746-021-00429-0

Stamatis, C. A., Farlow, D. N., Mercaldi, C., Suh, M., Maple, A., Savarese, A., Childress, A., Melmed, R. D., & Kollins, S. H. (2024). Two single arm trials of AKL-T01, a digital therapeutic for adolescents and adults with ADHD. Npj Mental Health Research 2024 3:1, 3(1), 1–10.

Konaç, A., Bini, M., Fusco, N., & Bourdin-Kreitz, P. (2024). Enhancing Executive Function Skills in Children With Attention-Deficit/Hyperactivity Disorder via Immersive Virtual Reality Interventions: Scoping Review. JMIR XR Spatial Comput 2024;1:E57225

Romero-Ayuso, D., Toledano-González, A., Rodríguez-Martínez, M. del C., Arroyo-Castillo, P., Triviño-Juárez, J. M., González, P., Ariza-Vega, P., Del Pino González, A., & Segura-Fragoso, A. (2021). Effectiveness of Virtual Reality-Based Interventions for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis. Children, 8(2), 70.

Păsărelu, C. R., Andersson, G., & Dobrean, A. (2020). Attention-deficit/ hyperactivity disorder mobile apps: A systematic review. International Journal of Medical Informatics, 138, 104133.

Capistrán, J. H.-, Alor-Hernández, G., Sánchez-Morales, L. N., & Machorro-Cano, I. (2023). Apps for ADHD Management: A Scoping Review.

Ayano, G., Demelash, S., Gizachew, Y., Tsegay, L., & Alati, R. (2023). The global prevalence of attention deficit hyperactivity disorder in children and adolescents: An umbrella review of meta-analyses. Journal of Affective Disorders, 339, 860–866.

Sibley, M. H., Bruton, A. M., Zhao, X., Johnstone, J. M., Mitchell, J., Hatsu, I., Arnold, L. E., Basu, H. H., Levy, L., Vyas, P., Macphee, F., Gonzalez, E. S., Kelley, M., Jusko, M. L., Bolden, C. R., Zulauf-McCurdy, C., Manzano, M., & Torres, G. (2023). Non-pharmacological interventions for attention-deficit hyperactivity disorder in children and adolescents. The Lancet Child and Adolescent Health, 7(6), 415–428.

Pollak, Y., Dekkers, T. J., Shoham, R., & Huizenga, H. M. (2019). Risk-Taking Behavior in Attention Deficit/Hyperactivity Disorder (ADHD): a Review of Potential Underlying Mechanisms and of Interventions. Current Psychiatry Reports, 21(5), 1–11.

Baweja, R., Faraone, S. V., Childress, A. C., Weiss, M. D., Loo, S. K., Wilens, T. E., & Waxmonsky, J. G. (2024). From Consensus Statement to Pills to Pixels: New Innovations in Attention-Deficit/Hyperactivity Disorder Care. Journal of Child and Adolescent Psychopharmacology, 34(4), 167–182.

Koirala, S., Grimsrud, G., Mooney, M. A., Larsen, B., Feczko, E., Elison, J. T., Nelson, S. M., Nigg, J. T., Tervo-Clemmens, B., & Fair, D. A. (2024). Neurobiology of attention-deficit hyperactivity disorder: historical challenges and emerging frontiers. Nature Reviews Neuroscience 2024 25:12, 25(12), 759–775.

Boudreau, A., & Mah, J. W. T. (2020). Predicting Use of Medications for Children with ADHD: The Contribution of Parent Social Cognitions. Journal of the Canadian Academy of Child and Adolescent Psychiatry, 29(1), 26.

Childress, A. C., Cutler, A. J., Marraffino, A., McDonnell, M. A., Turnbow, J. M., Brams, M., DeSousa, N. J., Incledon, B., Sallee, F. R., & Wigal, S. B. (2020). A Randomized, Double-Blind, Placebo-Controlled Study of HLD200, a Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder: An Evaluation of Safety and Efficacy Throughout the Day and Across Settings. Journal of Child and Adolescent Psychopharmacology, 30(1), 2.

ADHANSIA XR (methylphenidate hydrochloride) extended-release capsules, for oral use, CII. (n.d.). Retrieved December 11, 2024, from https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212038Orig1s000lbl.pdf

Katzman, M. A., Mattingly, G., Klassen, L. J., Cataldo, M. J., & Donnelly, G. A. E. (2020). Randomized Controlled Crossover Trials of the Pharmacokinetics of PRC-063, a Novel Multilayer Extended-Release Formulation of Methylphenidate, in Healthy Adults. Journal of Clinical Psychopharmacology, 40(6), 579–587.

Childress, A. C., Brams, M. N., Cutler, A. J., Donnelly, G. A. E., & Bhaskar, S. (2020). Efficacy and Safety of Multilayer, Extended-Release Methylphenidate (PRC-063) in Children 6-12 Years of Age with Attention-Deficit/Hyperactivity Disorder: A Laboratory Classroom Study. Journal of Child and Adolescent Psychopharmacology, 30(10), 580–589.

Cataldo, M., Donnelly, G., Cutler, A. J., Childress, A., Mikl, J., Bhaskar, S., & Waxmonsky, J. (2022). Analysis of Daily Sleep Diary Measures From Multilayer Extended-Release Methylphenidate (PRC-063) Studies in Children and Adults With ADHD. Journal of Attention Disorders, 26(14), 1870–1881.

Kollins, S. H., Braeckman, R., Guenther, S., Barrett, A. C., Mickle, T. C., Oh, C., Marraffino, A., Cutler, A. J., & Brams, M. N. (2021). A Randomized, Controlled Laboratory Classroom Study of Serdexmethylphenidate and d-Methylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology, 31(9), 597–609.

Braeckman, R., Guenther, S., Mickle, T. C., Barrett, A. C., Smith, A., & Oh, C. (2022). Dose Proportionality and Steady-State Pharmacokinetics of Serdexmethylphenidate/Dexmethylphenidate, a Novel Prodrug Combination to Treat Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology, 32(5), 288–295.

Barnhardt, E. A., Narayanan, A. R., & Coury, D. L. (2023). Evaluating serdexmethylphenidate and dexmethylphenidate capsules as a once-daily treatment option for ADHD. Expert Opinion on Pharmacotherapy, 24(11), 1215–1219.

Childress, A. C., Marraffino, A., Cutler, A. J., Oh, C., & Brams, M. N. (2023). Safety and Tolerability of Serdexmethylphenidate/Dexmethylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder: A 12-Month, Open-Label Safety Study. Journal of Child and Adolescent Psychopharmacology, 33(2), 51–58.

Faraone, S. V., Childress, A. C., Gomeni, R., Rafla, E., Kando, J. C., Dansie, L., Naik, P., & Pardo, A. (2023). Efficacy of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder: Effect Size Across the Day. Journal of Child and Adolescent Psychopharmacology, 33(1), 14–19.

Pardo, A., Kando, J. C., King, T. R., Rafla, E., & Herman, B. K. (2020). Single-dose pharmacokinetics of amphetamine extended-release tablets compared with amphetamine extended-release oral suspension. CNS Spectrums, 25(6), 774–781.

Allain, J. E., & Ganem, J. A. (2024). Dextroamphetamine Transdermal Patch: A Treatment Option for Attention-Deficit/Hyperactivity Disorder. Journal for Nurse Practitioners, 20(5). https://doi.org/10.1016/j.nurpra.2024.104993

Cutler, A. J., Suzuki, K., Starling, B., Balakrishnan, K., Komaroff, M., Castelli, M., Meeves, S., & Childress, A. C. (2022). Efficacy and Safety of Dextroamphetamine Transdermal System for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Results from a Pivotal Phase 2 Study. Journal of Child and Adolescent Psychopharmacology, 32(2), 89–97.

Childress, A., & Vaughn, N. (2024). A critical review of the dextroamphetamine transdermal system for the treatment of ADHD in adults and pediatric patients. Expert Review of Neurotherapeutics, 24(5), 457–464.

Cutler, A. J., Suzuki, K., Starling, B., Balakrishnan, K., Komaroff, M., Meeves, S., Castelli, M., & Childress, A. (2023). d-Amphetamine Transdermal System in Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: Secondary Endpoint Results and Post Hoc Effect Size Analyses from a Pivotal Trial. Journal of Child and Adolescent Psychopharmacology, 33(5), 176–182.

Childress, A., & Burton, S. (2022). Evaluating the pharmacokinetics of extended release viloxazine in the treatment of children with attention-deficit/hyperactivity disorder. Expert Opinion on Drug Metabolism & Toxicology, 18(6), 357–366.

Yu, C., Garcia-Olivares, J., Candler, S., Schwabe, S., & Maletic, V. (2020). New Insights into the Mechanism of Action of Viloxazine: Serotonin and Norepinephrine Modulating Properties. Journal of Experimental Pharmacology, 12, 285–300.

Nasser, A., Gomeni, R., Hull, J., Maldonado-Cruz, Z., Earnest, J., & Rubin, J. (2023). Evaluating the Impact of Caffeine on the Incidence of Adverse Events During Treatment with Viloxazine Extended-Release (Qelbree®) in Adults with ADHD. CNS Spectrums, 28(2), 234–235. https://doi.org/10.1017/S1092852923001621

Yu, C. L., Kao, Y. C., Thompson, T., Stubbs, B., Tseng, P. T., Hsu, C. W., Yang, F. C., Tu, Y. K., Hsu, T. W., & Liang, C. S. (2024). Response Trajectories and Temporal Trends of Viloxazine Treatment for Young People With ADHD: A Meta-Analysis. JAMA Network Open, 7(11), e2445885. https://doi.org/10.1001/JAMANETWORKOPEN.2024.45885

Faison, S. L., Fry, N., Adewole, T., Odebo, O., Schwabe, S., Wang, Z., Maletic, V., & Nasser, A. (2021). Pharmacokinetics of Coadministered Viloxazine Extended-Release (SPN-812) and Methylphenidate in Healthy Adults. Clinical Drug Investigation, 41(2), 149–159.

Faison, S. L., Fry, N., Adewole, T., Odebo, O., Wang, Z., Maletic, V., & Nasser, A. (2021). Pharmacokinetics of Coadministered Viloxazine Extended-Release (SPN-812) and Lisdexamfetamine in Healthy Adults. Journal of Clinical Psychopharmacology, 41(2), 155–162.

Neuchat, E. E., Bocklud, B. E., Kingsley, K., Barham, W. T., Luther, P. M., Ahmadzadeh, S., Shekoohi, S., Cornett, E. M., & Kaye, A. D. (2023). The Role of Alpha-2 Agonists for Attention Deficit Hyperactivity Disorder in Children: A Review. Neurology International, 15(2), 697.

Naguy, A., Alayadhi, N., Al-Tajali, A., & Ozidu, V. (2024). 2024 FDA-approved psychotropic medications: A conspectus. Asian Journal of Psychiatry, 102.

Jain, R., Segal, S., Kollins, S. H., & Khayrallah, M. (2011). Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 50(2), 171–179.

Cortese, S. (2023). Evidence-based prescribing of medications for ADHD: where are we in 2023? Expert Opinion on Pharmacotherapy, 24(4), 425–434.

Naguy, A., Pridmore, S., Alwetayan, S., Elsori, D., & Alamiri, B. (2023). ADHD-A Clinician’s Bird’s Eye View of Current Status and New Vistas! Psychopharmacology Bulletin, 53(1), 46.

Schein, J., Cloutier, M., Gauthier-Loiselle, M., Catillon, M., Xu, C., Chan, D., & Childress, A. (2024). Assessment of centanafadine in adults with attention-deficit/hyperactivity disorder: A matching-adjusted indirect comparison vs lisdexamfetamine dimesylate, atomoxetine hydrochloride, and viloxazine extended-release. Journal of Managed Care & Specialty Pharmacy, 30(6), 528.

Surman, C. B. H., Walsh, D. M., Horick, N., DiSalvo, M., Vater, C. H., & Kaufman, D. (2023). Solriamfetol for Attention-Deficit/Hyperactivity Disorder in Adults: A Double-Blind Placebo-Controlled Pilot Study. The Journal of Clinical Psychiatry, 84(6).

Maiti, R., Mishra, A., Jena, M., Maji, S., Padhan, M., & Mishra, B. R. (2024). Efficacy and safety of dasotraline in attention-deficit hyperactivity disorder: A systematic review and meta-analysis. Indian Journal of Psychiatry, 66(4), 326–335.

IsHak, W. W., Meyer, A., Freire, L., Totlani, J., Murphy, N., Renteria, S., Salem, M., Chang, T., Abdelsalam, R., Khan, R., Chandy, T., Parrish, T., Hirsch, D., Patel, B., Steiner, A. J., Kim, S., Hedrick, R., Pechnick, R. N., & Danovitch, I. (2024). Overview of Psychiatric Medications in the Pipeline in Phase III Trials as of June 1, 2024: A Systematic Review. Innovations in Clinical Neuroscience, 21(7–9), 27.

Rubia, K., Westwood, S., Aggensteiner, P. M., & Brandeis, D. (2021). Neurotherapeutics for Attention Deficit/Hyperactivity Disorder (ADHD): A Review. Cells, 10(8).

Rubia, K. (2022). Neurotherapeutics for ADHD: Do they work? PsyCh Journal, 11(3), 419–427.

Westwood, S. J., Radua, J., & Rubia, K. (2021). Noninvasive brain stimulation in children and adults with attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. Journal of Psychiatry & Neuroscience : JPN, 46(1), E14–E33.

Memon, A. M. (2021). Transcranial Magnetic Stimulation in Treatment of Adolescent Attention Deficit/Hyperactivity Disorder: A Narrative Review of Literature. Innovations in Clinical Neuroscience, 18(1–3), 43.

Chen, Y. H., Liang, S. C., Sun, C. K., Cheng, Y. S., Tzang, R. ‐F, Chiu, H. ‐J, Wang, M. Y., Cheng, Y. C., & Hung, K. C. (2023). A meta-analysis on the therapeutic efficacy of repetitive transcranial magnetic stimulation for cognitive functions in attention-deficit/hyperactivity disorders. BMC Psychiatry, 23(1).

Narmashiri, A., & Akbari, F. (2023). The Effects of Transcranial Direct Current Stimulation (tDCS) on the Cognitive Functions: A Systematic Review and Meta-analysis. Neuropsychology Review.

Brauer, H., Breitling-Ziegler, C., Moliadze, V., Galling, B., & Prehn-Kristensen, A. (2021). Transcranial direct current stimulation in attention-deficit/hyperactivity disorder: A meta-analysis of clinical efficacy outcomes. Progress in Brain Research, 264, 91–116.

Salehinejad, M. A., Nejati, V., Mosayebi-Samani, M., Mohammadi, A., Wischnewski, M., Kuo, M. F., Avenanti, A., Vicario, C. M., & Nitsche, M. A. (2020). Transcranial Direct Current Stimulation in ADHD: A Systematic Review of Efficacy, Safety, and Protocol-induced Electrical Field Modeling Results. Neuroscience Bulletin, 36(10), 1191–1212.

Westwood, S. J., Conti, A. A., Tang, W., Xue, S., Cortese, S., & Rubia, K. (2023). Clinical and cognitive effects of external trigeminal nerve stimulation (eTNS) in neurological and psychiatric disorders: a systematic review and meta-analysis. Molecular Psychiatry, 28(10), 4025–4043.

Huus, C.-M. L., Edemann-Callesen, H., Darling-Rasmussen, P., Martinsen, Ø. G., Bikic, A., & Storebø, O. J. (2023). The use of external Trigeminal Nerve Stimulation as an initial treatment for ADHD symptoms in children: A qualitative study of case series reports. Psychiatry Research Case Reports, 2(2), 100154.

McGough, J. J., Sturm, A., Cowen, J., Tung, K., Salgari, G. C., Leuchter, A. F., Cook, I. A., Sugar, C. A., & Loo, S. K. (2019). Double-Blind, Sham-Controlled, Pilot Study of Trigeminal Nerve Stimulation for Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 58(4), 403-411.e3.

Moret, B., Donato, R., Nucci, M., Cona, G., & Campana, G. (2019). Transcranial random noise stimulation (tRNS): a wide range of frequencies is needed for increasing cortical excitability. Scientific Reports, 9(1).

Nejati, V., Dehghan, M., Shahidi, S., Estaji, R., & Nitsche, M. A. (2024). Transcranial random noise stimulation (tRNS) improves hot and cold executive functions in children with attention deficit-hyperactivity disorder (ADHD). Scientific Reports, 14(1).

Ornella, D. K., Noam, M., Shachar, H., Itai, B., Roi, C. K., & Mor, N. (2023). Transcranial random noise stimulation combined with cognitive training for treating ADHD: a randomized, sham-controlled clinical trial. Translational Psychiatry, 13(1).

Zhi, J., Zhang, S., Huang, M., Qin, H., Xu, H., Chang, Q., & Wang, Y. (2024). Transcutaneous auricular vagus nerve stimulation as a potential therapy for attention deficit hyperactivity disorder: modulation of the noradrenergic pathway in the prefrontal lobe. Frontiers in Neuroscience, 18, 1494272.

Cheung, T., Yee, B. K., Chau, B., Lam, J. Y. T., Fong, K. H., Lo, H., Li, T. M. H., Li, A. M., Sun, L., Beisteiner, R., & Cheng, C. P. W. (2024). Efficacy and safety of transcranial pulse stimulation in young adolescents with attention-deficit/hyperactivity disorder: a pilot, randomized, double-blind, sham-controlled trial. Frontiers in Neurology, 15.

Faraone, S. V., Bellgrove, M. A., Brikell, I., Cortese, S., Hartman, C. A., Hollis, C., Newcorn, J. H., Philipsen, A., Polanczyk, G. V., Rubia, K., Sibley, M. H., & Buitelaar, J. K. (2024). Attention-deficit/hyperactivity disorder. Nature Reviews Disease Primers 2024 10:1, 10(1), 1–21.

Gudka, R., Becker, K., Newlove-Delgado, T., & Price, A. (2024). Provision of digital health interventions for young people with ADHD in primary care: findings from a survey and scoping review. BMC Digital Health 2024 2:1, 2(1), 1–12.

Tamm, L., Loren, R. E. A., Peugh, J., & Ciesielski, H. A. (2021). The Association of Executive Functioning With Academic, Behavior, and Social Performance Ratings in Children With ADHD. Journal of Learning Disabilities, 54(2), 124–138.

Diamond, A. (2013). Executive Functions. Annual Review of Psychology, 64, 135.

Keshavan, M. S., Vinogradov, S., Rumsey, J., Sherrill, J., & Wagner, A. (2014). Cognitive training in mental disorders: update and future directions. The American Journal of Psychiatry, 171(5), 510–522.

Shams, T. A., Foussias, G., Zawadzki, J. A., Marshe, V. S., Siddiqui, I., Müller, D. J., & Wong, A. H. C. (2015). The Effects of Video Games on Cognition and Brain Structure: Potential Implications for Neuropsychiatric Disorders. Current Psychiatry Reports, 17(9).

Understanding DTx - Digital Therapeutics Alliance. (n.d.). Retrieved December 11, 2024, from https://dtxalliance.org/understanding-dtx/

Westwood, S. J., Parlatini, V., Rubia, K., Cortese, S., Sonuga-Barke, E. J. S., Banaschewski, T., Baeyens, D., Bölte, S., Brandeis, D., Buitelaar, J., Carucci, S., Coghill, D., Daley, D., Döpfner, M., Ferrin, M., Galera, C., Hollis, C., Holtmann, M., Purper-Ouakil, D., … Zuddas, A. (2023). Computerized cognitive training in attention-deficit/hyperactivity disorder (ADHD): a meta-analysis of randomized controlled trials with blinded and objective outcomes. Molecular Psychiatry 2023 28:4, 28(4), 1402–1414.

He, F., Qi, Y., Zhou, Y., Cao, A., Yue, X., Fang, S., & Zheng, Y. (2023). Meta-analysis of the efficacy of digital therapies in children with attention-deficit hyperactivity disorder. Frontiers in Psychiatry, 14.

Oh, S. A., Choi, J., Han, D. H., & Kim, E. Y. (2024). Effects of game-based digital therapeutics on attention deficit hyperactivity disorder in children and adolescents as assessed by parents or teachers: a systematic review and meta-analysis. European Child & Adolescent Psychiatry, 33(2), 481–493.

Liu, X., Yang, Y., Ye, Z., Wang, F., Zeng, K., Sun, Y., Huang, Y., & Dai, L. (2024). The effect of digital interventions on attention deficit hyperactivity disorder (ADHD): A meta-analysis of randomized controlled trials. Journal of Affective Disorders, 365, 563–577.

Zhan, J., Liu, C., Wang, Z., Cai, Z., & He, J. (2024). Effects of game-based digital interventions for mental disorders: A meta-analysis. Journal of Affective Disorders, 362, 731–741.

Gobet, F., & Sala, G. (2023). Cognitive Training: A Field in Search of a Phenomenon. Perspectives on Psychological Science : A Journal of the Association for Psychological Science, 18(1), 125–141.

Sala, G., Deniz Aksayli, N., Semir Tatlidil, K., Tatsumi, T., Gondo, Y., & Gobet, F. (2019). Near and far transfer in cognitive training: A second-order meta-analysis. Collabra: Psychology, 5(1).

Kassai, R., Futo, J., Demetrovics, Z., & Takacs, Z. K. (2019). A meta-analysis of the experimental evidence on the near- and far-transfer effects among children’s executive function skills. Psychological Bulletin, 145(2), 165–188.

Instructions For Use | EndeavorRx®. (n.d.). Retrieved December 9, 2024, from https://www.endeavorrx.com/instructions-for-use/

Kollins, S. H., DeLoss, D. J., Cañadas, E., Lutz, J., Findling, R. L., Keefe, R. S. E., Epstein, J. N., Cutler, A. J., & Faraone, S. V. (2020). A novel digital intervention for actively reducing severity of paediatric ADHD (STARS-ADHD): a randomised controlled trial. The Lancet Digital Health, 2(4), e168–e178.

Kollins, S. H., Childress, A., Heusser, A. C., & Lutz, J. (2021). Effectiveness of a digital therapeutic as adjunct to treatment with medication in pediatric ADHD. NPJ Digital Medicine, 4(1). https://doi.org/10.1038/S41746-021-00429-0

Stamatis, C. A., Farlow, D. N., Mercaldi, C., Suh, M., Maple, A., Savarese, A., Childress, A., Melmed, R. D., & Kollins, S. H. (2024). Two single arm trials of AKL-T01, a digital therapeutic for adolescents and adults with ADHD. Npj Mental Health Research 2024 3:1, 3(1), 1–10.

Konaç, A., Bini, M., Fusco, N., & Bourdin-Kreitz, P. (2024). Enhancing Executive Function Skills in Children With Attention-Deficit/Hyperactivity Disorder via Immersive Virtual Reality Interventions: Scoping Review. JMIR XR Spatial Comput 2024;1:E57225

Romero-Ayuso, D., Toledano-González, A., Rodríguez-Martínez, M. del C., Arroyo-Castillo, P., Triviño-Juárez, J. M., González, P., Ariza-Vega, P., Del Pino González, A., & Segura-Fragoso, A. (2021). Effectiveness of Virtual Reality-Based Interventions for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis. Children, 8(2), 70.

Păsărelu, C. R., Andersson, G., & Dobrean, A. (2020). Attention-deficit/ hyperactivity disorder mobile apps: A systematic review. International Journal of Medical Informatics, 138, 104133.

Capistrán, J. H.-, Alor-Hernández, G., Sánchez-Morales, L. N., & Machorro-Cano, I. (2023). Apps for ADHD Management: A Scoping Review.